848825-79-6

Basic information

• Product Name: Benzaldehyde, 3,5-bis(trifluoromethyl)-, oxime
• CAS NO: 848825-79-6
• Molecular Formula: C9H5F6NO
• Molecular Weight: 257.135
• Mol File: 848825-79-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3,5-bis(trifluoromethyl)-, oxime(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3,5-bis(trifluoromethyl)-, oxime(848825-79-6)
• EPA Substance Registry System: Benzaldehyde, 3,5-bis(trifluoromethyl)-, oxime(848825-79-6)

Safety Data

• Hazardous Substances Data: 848825-79-6(Hazardous Substances Data)

Upstream product

• 401-95-6 3,5-Bis(trifluoromethyl)benzaldehyde 

Downstream Products

• 1207114-02-0 C₁₉H₁₃ClF₆N₂O₂ 
• 1453196-69-4 C₂₀H₁₈F₆N₂O₂ 
• 1453196-51-4 (R)-N¹-benzyl-N²-[3,5-bis(trifluoromethyl)benzyl]-N²-hydroxypropane-1,2-diamine 
• 1453196-50-3 (S)-N¹-benzyl-N²-[3,5-bis(trifluoromethyl)benzyl]-N²-hydroxypropane-1,2-diamine 
• 788138-65-8 1-[3,5-bis(trifluoromethyl)phenyl]-N-hydroxymethanamine 
• 85068-29-7 3,5-bis-trifluoromethylbenzylamine 
• 1235471-17-6 3-[3,5-bis(trifluoromethyl)phenyl]isoxazole-5-carboxylic acid 
• 1235471-12-1 ethyl 3-[3,5-bis(trifluoromethyl)phenyl]isoxazole-5-carboxylate 
• 1235471-30-3 3-[3,5-bis(trifluoromethyl)phenyl]isoxazole-5-carboxylic acid 2,6-dichloro-4-nitrophenylamide 
• 902492-10-8 N-hydroxy-3,5-bis(trifluoromethyl)benzimidoyl chloride 
• 27126-93-8 3,5-bis(trifluoromethyl)benzonitrile 

Relevant articles and documents

Design, synthesis and evaluation of novel levoglucosenone derivatives as promising anticancer agents

A series of levoglucosenone-derived 1,2,3-triazoles and isoxazoles featuring a flexible spacer between the heteroaromatic and anhydropyranose cores have been designed and synthesized following an hetero Michael // 1,3-dipolar cycloaddition path. The use o

Modified Fullerenes for Efficient Electron Transport Layer-Free Perovskite/Fullerene Blend-Based Solar Cells

A variety of novel chemically modified fullerenes, showing different electron-accepting capabilities, has been synthesized and used to prepare electron transport layer (ETL)-free solar cells based on perovskite/fullerene blends. In particular, isoxazolino[60] fullerenes are proven to be a good candidate for processing blend films with CH3NH3PbI3 and obtaining enhanced power conversion efficiency (PCE) ETL-free perovskite solar cells (PSCs), improving the state-of-the-art PCE (i.e., 14.3 %) for this simplified device architecture. A beneficial effect for pyrazolino and methano[60]fullerene derivatives versus pristine [60]/fullerene is also shown. Furthermore, a clear correlation between the LUMO energy level of the fullerene component and the open circuit voltage of the solar cells is found. Apart from the new knowledge on innovative fullerene derivatives for PSCs, the universality and versatility of perovskite/fullerene blend films to obtain efficient ETL-free PSCs is demonstrated.

Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423

We recently identified bis(amide) CCG-1423 (1) as a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis. An initial structure-activity relationship study focusing on bioisosteric replacement of the amides and conformational restriction identified two compounds, 4g and 8, with improved selectivity for inhibition of RhoA/C-mediated gene transcription and attenuated cytotoxicity relative to 1. Both compounds were also capable of inhibiting cell invasion with equal efficacy to 1 but with less attendant cytotoxicity.